Skip to main content

PharmTeam’s Activity

Tue Oct 15

NL

Article

PharmTeam published an article 12:01 PM

3 Things to Watch in Amgen's Earnings Report

The Onyx integration, Enbrel sales, and PCSK9 development are all important things to watch at Amgen.

Fri Oct 11

NL

Article

PharmTeam published an article 4:23 PM

A Health Care Portfolio for the Ages

Biotech companies Gilead Sciences and Celgene kick off the start of a market-beating diversified health care portfolio.

Thu Oct 10

NL

Article

PharmTeam published an article 4:09 PM

Are Pfizer's Xeljanz Results a Boost for Amgen?

Pfizer's Xeljan's performed fine in a trial for psoriasis, but will safety issues derail the drug's label expansion?

Thu Oct 3

NL

Article

PharmTeam published an article 11:24 AM

Will This Company Face the Same Restructuring as Merck?

Eli Lilly is facing some of the same problems as fellow big pharma companies Merck and AstraZeneca.

Mon Sep 30

NL

Article

PharmTeam published an article 10:36 AM

Which Alzheimer's Fighter Will Benefit From a Boost in Federal Funding?

One of these companies will receive $33 million for a special Alzheimer's trial.

Fri Sep 27

NL

Article

PharmTeam published an article 11:00 AM

The "Foolish" Way to Invest in Biotech

How can we Foolishly invest in an industry dominated by short-term catalysts?

Wed Sep 11

NL

Article

PharmTeam published an article 3:45 PM

A Pharmacology Primer for Biotech Investors

Here's one way new investors can think about drug development.

Tue Sep 3

NL

Article

PharmTeam published an article 1:22 PM

Digging Deeper Into This Heart Failure Drug's Miss

Did omecamtiv mecarbil miss its clinical goal as badly as the market thinks it did?

CAPS Stats & Trivia

CAPS Player Rating 64.13
Player Rank 21566 out of 60124
Score 2683.00
Score Change Today +2.93
Accuracy 44.74%
Active Picks 45
Total Picks 76
Best Pick AAPL (+706.50)
Worst Pick TVIA (-247.18)
Average Score per Pick 35.30
Charms Earned 10
Highest Rated Favorite No Favorites Selected
Go to PharmTeam’s CAPS page

Boards Stats & Trivia

Board Posts 40
Recs Received 51
People who have rec'd these posts 30
Recs to Posts Ratio (last 30 days) N/A
Threads Started 14
Threads Started Percentage 35.00 %
Most Frequent Board Premium Boards
Very First Post A $: Amazon.com post. (12/1/2013)
Percentage of Posts Rec'd 57.50 %
Show PharmTeam’s 10 Latest Posts
The Motley Fool respects your privacy and strive to be transparent about our data collection practices. We use your information to customize the site for you, to contact you about your membership, provide you with promotional information, and in aggregate to help us better understand how the service is used. For more details, please review our Privacy Policy.